Search

everythinglearnresearchcommunity

for

Search:↓

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Combining CGF and microneedling with betamethasone effectively treats resistant alopecia areata.

Exosomes can help promote hair growth and may treat hair loss.

Using a laser with bimatoprost solution works better for hair regrowth in alopecia areata than bimatoprost alone.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.

Medicinal herbs might treat hair loss by affecting genes and pathways related to lipid and glycerophospholipid metabolism.

Extracellular vesicles show promise for wound healing, but more research is needed to improve their stability and production.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

New cancer treatments aim to reduce side effects and improve effectiveness.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Nano-Pulse Stimulation™ Therapy is more effective and less damaging than cryoablation for treating melanoma tumors in mice.

Alopecia areata causes a significant economic burden in Japan, mainly due to productivity loss.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Significant progress and collaborations in stem cell research and regenerative medicine were made, including advancements in hair growth, cancer therapies, and treatments for neurological disorders.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

Hydrogel composites have great potential in regenerative medicine, tissue engineering, and drug delivery.

CRISPR/Cas9 gene-editing shows promise for improving sheep and goat breeding but faces challenges with efficiency and accuracy.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Inactive stem cells in hair follicles and muscles can avoid detection by the immune system.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.